Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)
| Autor: | Fensterer, H., Schade-Brittinger, C., Müller, H.-H., Tebbe, S., Fass, J., Lindig, U., Settmacher, U., Schmidt, W.E., Märten, A., Ebert, M.P., Kornmann, M., Hofheinz, R., Endlicher, E., Brendel, C., Barth, P.J., Bartsch, D.K., Michl, P., Gress, T.M. * |
|---|---|
| Zdroj: | In Annals of Oncology October 2013 24(10):2576-2581 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|